Rescuing Niemann-Pick C Disease: Pathways of Liver and Brain Degeneration

拯救尼曼匹克 C 病：肝脏和大脑退化的途径

• 批准号: 8081904
• 负责人: Matthew P. Scott
• 金额: $ 31.85万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-15 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8081904
• 关键词: Address; Affect; Alzheimer' s Disease; Animals; Astrocytes; Autophagocytosis; Axon; Binding Proteins; Brain; Brain Injuries; Brain imaging; Bypass; Categories; Cell Death; Cell physiology; Cells; Cerebellum; Cessation of life; Childhood; Cholesterol; Cognitive; Defect; Degenerative Disorder; Degradation Pathway; Dichloromethylene Diphosphonate; Disease; Disease Pathway; Disease Progression; Dyes; Employee Strikes; Engineering; Evaluation; Failure; Fibroblasts; Foundations; Genes; Genetic; Health; Hepatic; Hepatocyte; Hepatomegaly; Histocompatibility Testing; ITGAM gene; Immune; Inflammation; Inflammatory; Intracellular Transport; Label; Lead; Learning; Life; Liposomes; Liver; Location; Locomotion; Lysosomes; Measures; Microglia; Microscope; Monitor; Movement; Mus; Mutation; Nerve Degeneration; Neurodegenerative Disorders; Neuroglia; Neurons; Opitz trigonocephaly syndrome; Organelles; Pathology; Pathway interactions; Patients; Process; Production; Property; Proteins; Quantum Dots; Regulation; Role; Sirolimus; Staging; Sterols; Structure of thyroid parafollicular cell; Supraoptic Vertical Ophthalmoplegia; System; Technology; Testing; Tetanus Helper Peptide; Therapeutic; Therapeutic Intervention; Time; Tissues; Toxin; Transgenes; Transmembrane Domain; Virus; Virus Diseases; Work; cell injury; cell type; effective therapy; experience; falls; functional restoration; gene therapy; human TLR7 protein; improved; in vivo; insight; liver function; macrophage; mouse model; mutant; neuron component; novel strategies; prevent; relating to nervous system; research study; trafficking; two-photon

DESCRIPTION (provided by applicant): Niemann Pick type C (NPC) disease is a fatal pediatric disorder. The disease is due to mutations in either of two genes, NPC1, which encodes a 13 transmembrane domain sterol-binding protein, and NPC2, which encodes a soluble sterol-binding protein. Loss of either gene causes aberrant organelle trafficking and accumulation of free cholesterol within lysosomes. NPC patients suffer from hepatomegaly and progressive cognitive and locomotion losses, with massive Purkinje neuron (PN) death in the cerebellum. There is no effective treatment for NPC. Specific Aim 1: Determine why Purkinje neurons die in NPC disease and at what stages the disease can be arrested or reversed. We will provide a functional tagged- Npc1 protein to specific classes of cells, eg neurons, astrocyte, or liver cells, in the Npc1-/- background, to define how each cell type contributes to disease. Our transgenes are engineered with Tet-technology to allow cell-specific and temporal regulation of tagged Npc1 production. Specific Aim 2: Learn how NPC disease affects intracellular trafficking in Purkinje neurons. Loss of Npc1 causes striking intracellular trafficking defects in fibroblasts. To learn how PNs are affected, we will culture them and track the trafficking of NGF and other molecules labeled with quantum dots. We will use a portable two-photon microscope in combination with organelle dyes to characterize vesicular movements in living astrocytes and PNs of wild-type and Npc1-/- mice. In living brains of our newly engineered mice we will analyze movements of Npc1-positive organelles in PNs, other neurons, and astrocytes to determine what changes may cause cell death. Specific Aim 3: Determine whether inflammation protects from, or causes, NPC cell death. We will produce functional Npc1 in neurons, hepatocytes, and inflammatory cells, in otherwise Npc-/- mice, and see which of these is most effective in preventing inflammation. We will use mouse mutations that reduce inflammation in combination with Npc1-/-, and see whether PN survival and liver pathology are improved or worsened. We will ablate hepatic macrophages with chlodronate-filled liposomes and assess the role of macrophages in NPC liver damage. Specific Aim 4: Discover whether autophagy protects from, or causes, NPC cell death. We will cross NPC mice with mutants that cannot trigger autophagy: Toll like receptor-7 and beclin-1 deficient mice. Conversely we will test mice that have over-expressing Beclin1 in neurons and consequent have heightened autophagy, or enhance autophagy with Beclin1 virus infections or rapamycin treatments. Lysosome storage disorders like NPC encompass nearly 60 different conditions, most of which damage liver and/or brain function. Some, including NPC, have similarities to Alzheimer disease. We have used a novel approach to engineer mice that will allow us to learn how different cell types and processes contribute to disease. Learning the roles of inflammation and autophagy in NPC neurodegeneration has direct implications for therapeutic interventions that will arrest or reverse disease progression. PUBLIC HEALTH RELEVANCE: Niemann-Pick C syndrome is a neurodegenerative disorder involving failures of intracellular transport of organelles, and accumulation of large quantities of cholesterol, and these problems lead to liver and brain damage. We have engineered mice in which specific types of cells can be rescued from the disease while other cells remain mutant. We will use these mice to learn how different types of cells contribute to NPC disease pathology, and to investigate how inflammation, and attempts by cells to survive by consuming their own proteins, are involved in the deaths of neurons and liver cells.

描述(申请人提供)：Niemann Pick C型(NPC)病是一种致命的儿科疾病。这种疾病是由两个基因中的任何一个突变引起的，NPC1编码一个跨膜结构域的固醇结合蛋白13，NPC2编码一个可溶的固醇结合蛋白。任何一种基因的缺失都会导致细胞器的异常运输和溶酶体内游离胆固醇的积累。鼻咽癌患者肝脏肿大，进行性认知和运动能力丧失，伴有小脑大量浦肯野神经元(PN)死亡。鼻咽癌目前尚无有效的治疗方法。具体目标1：确定浦肯野神经元在鼻咽癌疾病中死亡的原因，以及在什么阶段可以阻止或逆转这种疾病。我们将在NPC1-/-背景中向特定类别的细胞，如神经元、星形胶质细胞或肝细胞提供功能性标记的NPC1蛋白，以确定每种细胞类型如何导致疾病。我们的转基因是用Tet技术设计的，允许对标记的NPC1生产进行细胞特异性和时间调节。具体目标2：了解鼻咽癌疾病如何影响浦肯野神经元的细胞内运输。NPC1的缺失导致成纤维细胞发生显著的细胞内转运缺陷。为了了解PNS是如何受到影响的，我们将对它们进行培养，并跟踪NGF和其他标记有量子点的分子的运输。我们将使用便携式双光子显微镜结合细胞器染料来表征活的星形胶质细胞和野生型和NPC1-/-小鼠的PNS中的囊泡运动。在我们新设计的小鼠的活脑中，我们将分析三叉神经节、其他神经元和星形胶质细胞中NPC1阳性细胞器的运动，以确定哪些变化可能导致细胞死亡。具体目标3：确定炎症是否保护或导致鼻咽癌细胞死亡。我们将在其他NPC-/-小鼠的神经元、肝细胞和炎症细胞中产生功能性NPC1，并看看其中哪一种在预防炎症方面最有效。我们将使用减少炎症的小鼠突变与NPC1-/-结合使用，看看PN存活率和肝脏病理是改善还是恶化。我们将用填充氯硝酸盐的脂质体去除肝巨噬细胞，并评估巨噬细胞在鼻咽癌肝损伤中的作用。具体目标4：发现自噬是否保护鼻咽癌细胞死亡，或导致鼻咽癌细胞死亡。我们将把鼻咽癌小鼠与不能触发自噬的突变小鼠进行杂交：Toll样受体-7和Beclin-1缺陷小鼠。相反，我们将测试在神经元中过度表达Beclin1并随之而来的自噬增强的小鼠，或者通过Beclin1病毒感染或雷帕霉素治疗增强自噬。像鼻咽癌这样的溶酶体储存障碍包括近60种不同的疾病，其中大多数损害肝脏和/或大脑功能。包括鼻咽癌在内的一些疾病与阿尔茨海默病有相似之处。我们使用了一种新的方法来改造小鼠，这将使我们能够了解不同的细胞类型和过程是如何导致疾病的。了解炎症和自噬在鼻咽癌神经变性中的作用对于阻止或逆转疾病进展的治疗干预具有直接意义。 公共卫生相关性：尼曼-皮克C综合征是一种神经退行性疾病，涉及细胞器内运输障碍，以及大量胆固醇积聚，这些问题会导致肝脏和大脑损伤。我们设计了一种小鼠，在这些小鼠中，特定类型的细胞可以从疾病中拯救出来，而其他细胞则保持突变。我们将利用这些小鼠来了解不同类型的细胞如何参与鼻咽癌疾病的病理，并研究炎症以及细胞试图通过消耗自己的蛋白质来生存，是如何参与神经元和肝细胞的死亡的。